September 25, 2007 - Findings in a new study, published in the February 2007 issue of Lasers in Surgery and Medicine, suggest a new way to help protect the skin during radiation therapy.

Conducted by Maitland DeLand M.D., oncologist and president of OncoLogics Inc., the study illustrates how GentleWaves LED Photomodulation, manufactured by Light BioScience, significantly reduced the incidence and degree of radiation-induced dermatitis.

September 25, 2007 - MEDRAD Inc. has partnered with the National Prostate Cancer Coalition (NPCC) to provide information about prostate magnetic resonance (MR) imaging to the men who participate in NPCC’s free mobile screening program.

September 25, 2007 - According to a study focusing on non-mass enhancing breast lesions, appearing in the October issue of the journal Radiology, proton magnetic resonance spectroscopy (1H MRS) used in conjunction with magnetic resonance imaging (MRI) can aid radiologists in diagnosing breast cancer while reducing the number of false-positive results and invasive biopsies

“All of the cancers present in this study were identified with MR spectroscopy,” said the study’s lead author, Lia Bartella, M.D., director of breast imaging at Eastside Diagnostic Imaging in New York City.

September 25, 2007 - According to a study published in the October issue of Radiology, researchers using functional magnetic resonance imaging (fMRI) have found a new marker that may aid in early diagnosis of Alzheimer’s disease.

“The findings of this study implicate a potential functional, rather than structural, brain marker—separate from atrophy—that may help enhance diagnosis and treatment monitoring of Alzheimer’s patients,” said the study’s lead author, Jeffrey R. Petrella, M.D., associate professor of radiology at Duke University Medical Center in Durham, N.C.

September 24, 2007 — Integra LifeSciences Holdings Corp. recently announced the release of the OCS2 Ojemann Cortical Stimulator at this week's annual meeting of the Congress of Neurological Surgeons in San Diego, CA.

The OCS2 Ojemann Cortical Stimulator has an FDA clearance in the United States and a CE Mark Certification in the European Union.

September 23, 2007 — Breast cancer survivors who took a weekly dose of risedronate, sold as Actonel, lost significantly less bone than those who did not take the drug, according to a two-year study from the University of Pittsburgh School of Medicine presented this week at the 29th annual meeting of the American Society for Bone and Mineral Research.

September 24, 2007 — Integra LifeSciences Holdings Corp. announced the launch of the Selector SaberTip for the CUSA Selector ultrasonic surgical aspirator system.

The new Selector SaberTip is designed for surgical applications requiring precise and controlled removal of bone and calcified tissues. The Selector SaberTip attaches to the CUSA Selector's 24 kHz neurosurgical short handpiece, offering surgeons market-leading bone-removal power and fine control, and significantly expanding the CUSA Selector system's surgical versatility and utility.

September 24, 2007 – The Society for Molecular Imaging and Nuclear Medicine (SNM) recently reported that based on the results of a recent National Academy of Sciences report, federal funding for basic molecular imaging/nuclear medicine research should be restored to the U.S. Department of Energy.

September 24, 2007 - SonoSite Inc. recently reported that its SonoMB, a new ultrasound technology that incorporates an imaging algorithm that reportedly improves contrast resolution and reduces ultrasound artifact, while providing excellent frame rates and image quality for the clinician, is now available on its curved array probes.

September 21, 2007 - Hologic Inc., a provider of diagnostic imaging and state-of-the-art digital imaging systems directed towards women’s health, recently announced the acquisition of BioLucent Inc., a market leader in its development and sale of its MammoPad breast cushion.

BioLucent, located in Aliso Viejo, California, develops, markets and sells a breast cushion, MammoPad, to decrease the discomfort associated with mammography. BioLucent’s primary research and development efforts are directed at its brachytherapy business which is focused on breast cancer therapy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now